Phlebologie, Table of Contents Phlebologie 1998; 27(03): 98-104DOI: 10.1055/s-0037-1616958 Leitlinien der Deutschen Gesellschaft für Phlebologie Schattauer GmbH Aktualisierte Fassung Leitlinien zur Thromboembolie-Prophylaxe[*] H. Partsch , W. Blättler Recommend Article Abstract Buy Article Full Text References Literatur 1 Nicolaides AN, Bergqvist D, Hull R. Prevention of venous thromboembolism. International Consensus Statement (Guidelines according to scientific evidence). Int Angiol 1997; 16: 3-38. 2 Hartel W. Empfehlungen zur stationären und ambulanten Thromboembolie-Prophylaxe in der Chirurgie. Expertengespräch zur Thromboembolieprophylaxe. Beilagen zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie. Heft 5/1997. 3 Hach-Wunderle V, Haas S. (Hrsg.). Thromboembolie-Prophylaxe in der inneren und operativen Medizin. Berlin, Heidelberg, New York: Springer; 1997 4 Prevention of venous thrombosis and pulmonary embolism (Consensus Conference, NIH). JAMA 1986; 256: 744-57. 5 Empfehlungen zur Thromboseprophylaxe bei ambulanten Patienten. Unfallchirurgie 1991; 17: 2-3. 6 European Consensus Statement.. Prevention of venous thromboembolism. Internat Angiology 1992; 11: 151-9. 7 Bergqvist D, Comerota A, Nicolaides AN, Scurr JH. Prevention of venous thromboembolism. London, Los Angeles, Nicosia: Med-Orion Publishing Company; 1994 8 Bounameaux H. Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases. New York: Marcel Dekker; 1994 9 Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127: 310-3. 10 Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-80. 11 Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348: 981-3. 12 Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-7. 13 Jorgensen PS, Strandberg C, Wille-Jorgensen P, Torholm C, Neergaard K, Paaske BP, Rasmussen SW, Christensen SM, Mantoni M, Thamsen H. Early preoperative thromboprophylaxis with Clexane in hip fracture surgery. A placebo controlled study. 14th Int Congress on Thrombosis. Montpellier Oct 14-19, 1996. Haemostasis 1996; 26 (Suppl. 3); 3. 14 Warkentin TE, Levine MN, Hirsh J, Horse-wood P, Roberts RS, Tech M, Kent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractioned heparin. N Engl J Med 1995; 332: 1330-4. 15 Arzneimittel-Schnellinformation (ASI 3/96) des BfArM. Deutsches Ärzteblatt 1996; 93: A 987. 16 Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Comparison of subcutaneous unfractioned heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994; 71: 7-11. 17 Eriksson BI, Ekman St, Kälebo P, Zachrisson B, Bach D, Close Ph. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996; 347: 635-9. 18 Partsch H, Kahn P. Venöse Strömungsbeschleunigung in Bein und Becken durch »Anti-Thrombose-Strümpfe«. Klinikarzt 1982; 11: 609-15. 19 Mercett ND, Hanel KC. Ischaemic complications of graduated compression stockings in the treatment of deep venous thrombosis. Postgrad Med J 1993; 69: 232-4. 20 Wulf H. Thromboembolieprophylaxe und rückenmarksnahe Regionalanästhesie. Anästh Intensivmed 1995; 36: 216-7. 21 Toglia MR, Weg JG. Venous thromboembolism during pregnancy. NEJM 1996; 335: 108-14.
